DOSE

The architecture
of a tablet.

The smallest objects can hold
the most deliberate design.

Enter the matter
Object view

Matter,
with purpose.

The active ingredient and excipients play different roles. Their forms and physical properties help shape the dosage form and its manufacture.

  • Active ingredient
  • Excipient matrix
  • Processing aids

Forms and colors are illustrative.

Particle view

Uniformity
is designed.

A mixture, before a form. Blending redistributes materials; differences in particle size, shape and density can also lead to segregation.

A visual distribution, not a measured result.

Powder view

A moment.
Made solid.

In a die, a powder blend becomes one coherent form. Opposing punches bring particles closer, rearranging and consolidating the bed.

Direct compression · Simplified geometry.

Die view
FillCompressRelease

The surface
holds a story.

A closer look at compressed matter. This tablet is uncoated: the surface belongs to a porous compact, with no separate shell.

Conceptual porosity · No measured dimensions.

Surface view

Beauty,
examined.

Appearance is one observation. Content uniformity examines active ingredient across individual units. Disintegration and dissolution ask different questions.

Conceptual reconstruction · Not scan data.

Within the form

Move the control to change the conceptual cutaway. Arrow keys make small changes; Home and End select the surface and interior. This is not a measurement.

Internal view

A form.
And what
comes after.

Structure meets liquid. Breakup exposes smaller particles; dissolution moves soluble material into solution. These are related, distinct processes.

Artistic timing · No clinical prediction.

Return to the beginning
Liquid contact Material. Scale. Deliberate design.
DOSE

One object.
Seven perspectives.

Enter anywhere.
Follow the material.
DOSE

Small object.
Considered world.

A visual study of the architecture within a tablet.

Your viewing experience

Preparing the material study.

One illustrative route

We follow a hypothetical, uncoated, immediate-release tablet through direct compression: prepared ingredients, blending, die filling, compaction, structure and contact with liquid. Granulation and film coating are not part of this chosen branch.

The particle forms, proportions, colors, motion and timing are conceptual. No real formulation, measured dimension, analytical result or clinical outcome is represented.

What the images can tell us

Excipients have functional roles. A visually even mixture is not proof of uniformity. The cutaway is original CGI, not a CT scan; the depth control explores its geometry and does not perform a test.

Disintegration is not dissolution. A tablet can break into particles that have not dissolved. Actual behavior depends on its materials and test conditions. This artwork gives no medication or manufacturing instructions.

Reading & references

  1. FDA / ICH Q8(R2) — Pharmaceutical development Functions and characteristics of formulation materials.
  2. Ishikawa et al., 2021 — Direct compression and granulation Different manufacturing routes; only direct compression is illustrated here.
  3. FDA — Oral solid dosage forms, 1994 Historical qualitative background on mixing and segregation.
  4. FDA / ICH Q6A — Specifications Quality attributes and dosage-unit testing.
  5. Ferdoush et al., 2023 — Water uptake and micro-CT Visual research context; original scan data is not used.
  6. FDA — Dissolution testing The distinct question of material entering solution.

Original procedural geometry and materials. Space Grotesk, Barlow Condensed and IBM Plex Mono, self-hosted under the SIL Open Font License. Built with Three.js and Lenis. Source and license details accompany this edition.